Floatz logo

Benadryl

Advanced Biliary Cancer

Merck Sharp & Dohme LLCPhase 1/2Active
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Advanced Biliary Cancer cohort.

Asset / SponsorPhaseRating
Fludarabine
Zhejiang University
Early Phase 1C
Anti-Ex02 Car T Cells
Zhang Xiaofeng,MD
Early Phase 1C

Same molecule, other indications

Benadryl is also rated in:

Relapsing Chronic Myelogenous LeukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Adult Hodgkin LymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
Recurrent Adult Acute Myeloid LeukemiaDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →